Conquering Chronic Inflammation Today
FOR A BETTER TOMORROW
We have identified a common thread in chronic inflammatory diseases through the use of machine learning and AI-based precision diagnostics.
This work has led to the creation of our patented diagnostic testing and pharmaceutical treatment platform.
HealthBio has discovered the root cause and potential solution for diagnosing and treating chronic inflammatory diseases with patient's suffering from:
FATIGUE
JOINT PAIN
BRAIN FOG
MUSCLE PAIN
AND WEAKNESS
HEADACHE
OR MIGRAINE
EXERCISE
INTOLERANCE
OUR MISSION
Develop solutions for millions of patients suffering from chronic inflammatory diseases worldwide
TODAY: WE ARE PURSUING THE DIAGNOSis AND TREATMENT of THESE CHRONIC INFLAMMATORY
DISEASES AND DISORDERS
INCIDENCE OF PREVALENT INFLAMMATORY
DISEASES/DISORDERS IN THE US
LONG COVID
22 Million
CHRONIC LYME
275K
FIBROMYALGIA
22Million
CHRONIC FATIGUE
SYNDROME (ME/CFS)
22Million
Tomorrow: Our ongoing research and development includes Oncology, Alzheimer's and Autoimmune Diseases
Executing the same clinical algorithm developed with our machine learning and AI Health Data platform allows us to pursue diagnosis and treatment solutions for many other chronic inflammatory diseases.
RESOURCE ARTICLE
Frontiers in Immunology
Persistent of Sars CoV-2 S1 Protein in CD16+ Monocytea in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection
HealthBio has cracked the code by identifying the molecular root cause of Long COVID and potentially other inflammatory diseases.
In Long Covid patients, the SI protein of the COVID-19 virus remains in their white blood cells, leading to a persistent immune response despite the absence of the active COVID-19 infection.
These white blood cells have many CCR5 and fractalkine receptors on their cell surface, which promote vascular inflammation and immune dysregulation through the monocytic-endothelial-platelet axis. We believe this is the primary root cause for adverse symptoms.
RESOURCES
